Halozyme Therapeutics Inc. buy Benchmark Co.
Start price
24.09.25
/
50%
€66.40
Target price
24.09.26
€76.27
Performance (%)
-3.80%
Price
01.10.25
€63.88
Summary
This prediction is currently active. With a performance of -3.80%, the BUY prediction by Benchmark_Co_ is trending in the wrong direction. This prediction currently runs until 24.09.26. The prediction end date can be changed by Benchmark_Co_ at any time. Benchmark_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Halozyme Therapeutics Inc. | -0.869% |
| iShares Core DAX® | 2.304% |
| iShares Nasdaq 100 | 1.287% |
| iShares Nikkei 225® | 0.404% |
| iShares S&P 500 | 1.202% |
Comments by Benchmark_Co_ for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics (NASDAQ:HALO) had its price target raised by analysts at Benchmark Co. from $75.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for HALO provided by MarketBeat
Stopped prediction by Benchmark_Co_ for Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€54.68
20.02.25
20.02.25
€71.72
20.02.26
20.02.26
16.83%
01.10.25
01.10.25
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€49.87
08.08.24
08.08.24
€55.00
08.08.25
08.08.25
10.25%
09.08.25
09.08.25
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€48.68
25.06.24
25.06.24
€56.00
25.06.25
25.06.25
-7.99%
26.06.25
26.06.25
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€36.23
16.04.24
16.04.24
€46.98
16.04.25
16.04.25
43.42%
17.04.25
17.04.25
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€31.35
19.01.24
19.01.24
€45.94
19.01.25
19.01.25
69.19%
20.01.25
20.01.25
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€33.23
20.10.23
20.10.23
€47.17
20.10.24
20.10.24
45.44%
21.10.24
21.10.24